proportion of patients with CF/ABPA and not in CF or controls, underlining the importance of this antigen in the diagnosis of ABPA. In contrast, a greater proportion of the CF group responded to P aeruginosa antigens compared with the controls and CF/ABPA. Hence, the CF and CF/ABPA groups respond to both P aeruginosa and A fumigatus antigens with the former group responding strongly to P aeruginosa and the latter to A fumigatus antigens.
( and ABPA, and healthy controls using both crude and purified A fumigatus antigens and antigens from both nonmucoid and mucoid variety of P aeruginosa. In addition, we have also studied the levels of IgE and IgG antibodies to both A fumigatus and P aeruginosa antigens. Data from this study show that the CF group respond strongly to P aeruginosa antigens while the CF/ABPA respond to Afumigatus antigens.
METHODS

Subjects
Three groups of subjects were included in this study. Patients with proven CF without ABPA (n=7) were selected from the regional cystic fibrosis center at the Medical College of Wisconsin. Patients with CF satisfying criteria for ABPA previously reported8 (CF/ABPA, n=7), and healthy individuals (healthy control, n=10) without ABPA served as controls. Patients with cystic fibrosis were diagnosed as having ABPA based on deterioration of pulmonary functions with (1) immediate cutaneous reactivity to A fumigatus, (2) Both noncapsulated (noncaps) and capsulated (caps) types of P aeruginosa were isolated from the sputa of patients with CF. The cultures were grown in synthetic medium for 24 hours at 370 C. The broth was then centrifuged at 10,000 revolutions per min (rpm) for 15 min. The bacteria were resuspended in PBS and homogenized using a French press at 10,000 psi. The homogenate was then centrifuged at 10,000 rpm for 30 min and the supernatant was dialyzed and lyophilized.
Antigen Specific Lymphocyte Proliferation
Proliferative assays were performed in 96 well flat bottom microtiter plates in medium alone and in presence of final concentrations of soluble A fumigatus or P aeruginosa antigens ranging from 100 jAg/ml to 2 mg/ml to determine the optimal dose. Peripheral blood mononuclear cells (PBMC) were obtained from heparinized blood by the method of Boyum.16 Cells (2X105/well) were cultured in RPMI 1640 supplemented with 2 mmol/L glutamine, penicillin (100 U/ml), streptomycin (100 ,4g/ml), and 10 percent fetal bovine serum (Hyclone, Utah) for 7 days, at 370 C in a humidified atmosphere containing 5 percent CO2. The cultures were pulsed with 0.5 gtCi/well of tritiated thymidine (specific activity, 6.7 Ci/mmol, New England Nuclear, Mass) for the final 18 hours of culture, harvested on glass fiber filter, and the radioactivity counted on a beta scintillation counter (Rack Beta, LKB, Sweden). Results were expressed as stimulation index (SI) as SI=cpm(antigen stimulated cultures)/cpm(medium alone cultures).
In Vitro Immunoglobulin Synthesis For in vitro immunoglobulin E (IgE) synthesis PBMC (2X106 cells/well) were cultured in medium alone or A fumigatus and P aeruginosa antigens for 7 days in 24 well-cluster plates as described previously." Supernatants were collected and made cell free by centrifugation at 1,000 g for 10 min and stored at-703 C before being tested for total IgE by BALISA described below.
Antigen Specific IgE and IgG
The BALISA as a sensitive and reliable quantitative measure of anti-A fumigatus specific IgG and IgE antibodies in the sera of patients has been described previously.'7 A modification of this method was used to measure Pseudomonas specific antibodies. Briefly, a mixture of culture filtrate and mycelial extract of A fumigatus antigens in PBS was used to coat each well of a microtiter plate (Dynatech Laboratories, Alexandria, Va) and incubated overnight at 40C. The P aeruginosa coated at 1:100 dilution for both caps and noncaps antigens. The wells were washed once with phosphate buffered saline solution containing 0.05 percent Tween 20 (PBS-T). The plates were stored at -700C until used. The wells were blocked by incubation at room temperature (RT) with 200 ,tl of PBS-T containing 1 percent bovine serum albumin (BSA-PBS-T). The wells were washed thrice with PBS-T.
All dilutions of the serum in the assay were made with the blocking solution. The samples (1:50 diluted serum for IgE, 1:1,000 for IgG or undiluted supernatants) were added to wells and plate incubated at RT for 3 hours. To detect IgE, this step was followed up by goat antihuman IgE (Sigma, St. Louis, Mo) at a 1:1,000 dilution for 1 hour. Subsequent steps included addition of 1:5,000 diluted biotinylated rabbit antigoat IgG (Zymed Laboratories, San Francisco, Calif) and 1:20,000 diluted streptavidin peroxidase (Sigma, St. Louis) with incubations of 1 hour each. For IgG, biotinylated goat antihuman IgG was added followed by streptavidin peroxidase.
The wells were washed thrice as above after each incubation. Leukotriene B4 Production Peripheral blood mononuclear cells from four CF, three CF/ ABPA, and five healthy controls selected randomly were obtained as described above. Cells (1X106/ml) were incubated with calcium ionophore (A 23187, Calbiochem, La Jolla, Calif) for 30 min at 37°C, and supernatants were assayed for leukotriene B4 (LTB4) directly using a radioimmunoassay (RIA) as described earlier. '8 The RIA used (Amersham, Arlington Heights, Ill) was sensitive to 1.6 pg/ml and had the following cross-reactivities; LTC4 and LTD4, <0.05%; 5-, 12-, and 15-HETE, <0.05%; and 20-OH-LTB4, 0.4%.
Statistical Analysis
The data was analyzed using Student's t test (two-tailed, independent samples). A p value of less than 0.05 was considered statistically significant. RESULTS
Antigens
The A fumigatus antigens-culture filtrate (AF 5302), mycelial extract (MK6), and Con A nonbinding were diluted to a stock concentration of 1 mg/ml, 200 ,ug/ml, and 6 mg/ml of total protein respectively. tus antigen. The capsulated P aeruginosa antigen has fewer protein bands than noncapsulated P aeruginosa antigens. Antigen-Induced Lymphocyte Transformation Con A nonbinding antigen was used at 1:250 dilution while all other A fumigatus antigens were used at 1:1,000. The P aeruginosa antigens were used at 1:500 dilution. The dose of antigens used in this study was decided by preliminary experiments. Table 1 shows the mean response to A fumigatus and P aeruginosa antigen in each test group and the number of responders to each antigen. The range of responses by individuals in all three groups was broad (Fig 1) , making the mean values less representative of the group. Hence, to compare different groups, we established the Mean+2 SD of SI value of the lymphocyte response to each antigen by PBMC from healthy controls as an arbitrary standard. Any individual response with an SI value higher than this standard was designated a responder to that dose of antigen.
The lymphocyte transformation response to crude A fumigatus antigens (culture filtrate, mycelial extract) failed to distinguish between the various groups. Those to purified A fumigatus antigens (Con A nonbinding, Con A binding) were more discriminatory. The CF/ABPA group responded specifically to Con A nonbinding antigen in both their mean response and the number of responders, while the CF group responded specifically to Con A binding antigen.
The response to P aeruginosa antigen by the patient groups varied widely. The mean response to both capsulated and noncapsulated antigens by the CF group was higher than the CF/ABPA group. Furthermore, the number of responders in the CF group was higher. A fumigatus and P aeruginosa Specific Antibodies in Serum
As no universal standard for quantitation of A fumigatus or P aeruginosa specific antibodies is available, we are reporting the data in optical density (OD) values. To eliminate variability all samples were tested by ELISA for a particular antibody on the same day under identical conditions. Both CF and CF/ABPA groups had significant levels of A fumigatus specific IgG in sera compared with controls ( Table 2 ). The groups also had significant increases in IgE antibodies to P aeruginosa antigens. Statistically higher levels of IgE specific to capsulated than to noncapsulated antigen was shown ( Table 2 ). The P aeruginosa specific IgG was not significantly elevated in the patient groups.
Specific Antibodies in Culture Supernatants
In contrast to P aeruginosa specific antibody levels in serum, the specific IgG in 7-day PBMC culture fluids from the patient groups were elevated compared with controls. Patients with CF produced higher levels of antibodies to P aeruginosa antigens than the CF/ABPA group (Table 3) . A fumigatus specific antibodies were negligible in all groups tested (data not shown).
LTB4 in Culture Supernatants
The PBMC from CF/ABPA (2,367 ± 145 pg/ml) group produced significant levels of LTB4 compared with both CF (1,225 ± 347) and control (1,560 ± 280) groups.
DISCUSSION
Patients with CF are unusually susceptible to recurrent and chronic bacterial colonization in the lower respiratory tract. There is a high prevalence of bronchopulmonary infection with mucoid P aeruginosa. Several reports have also highlighted an increase in allergy skin prick test reactivity and increased levels of total and specific IgE antibodies in CF. 19 Major atopic responses are to A fumigatus a ubiquitous fungus, which is known to complicate CF with ABPA. As Aspergillus allergy appears coincident with P aeruginosa it is difficult to distinguish the host immune response to the two organisms. In the present study, the immune response to both P aeruginosa and A fumigatus antigens in CF and CF/ABPA were studied to try and make a diagnostic distinction between these two responses. In our earlier study with ABPA, it was shown that the Con A nonbinding fraction of A fumigatus was more specific to the disease." In the present study, the lymphocyte transformation response to A fumigatus culture filtrate and mycelial extract antigen in both CF and CF/ABPA were no different from that of the control group. The A fumigatus is a common fungus in the environment and the exposed population has been shown by us1l and others20'21 to respond rather uniformly to crude preparations from this fungus. The purified fractions of Con While a greater proportion of the CF/ABPA group responded in in vitro culture to A fumigatus antigens (except Con A binding) the CF group responded better to P aeruginosa antigens. The underlying fungal infection seen in the former could give rise to such differences. Several P aeruginosa components including proteases,24'25 slime layer antigens,26'27 and outer membrane proteins28 are capable of stimulating cell mediated immunity. Heat-killed P aeruginosa was mitogenic for human lymphocytes and induced production of TNF-alpha and IL-1.29 Lymphocyte unresponsiveness to killed P aeruginosa with progression of pulmonary disease, however, has been reported. 3032 The levels of LTB4 in CF/ABPA, a significant inflammatory mediator in chronic pseudomonal respiratory disease, was elevated consistent with the chronic production of LTB4 noted by others. 33 The presence of Aspergillus specific antibodies in both CF and CF/ABPA group in the present study has been described previously. The A fumigatus specific antibodies in CF/ABPA patients have also been shown by Knutsen et al.3435 They have suggested the possibility of a subclinical pulmonary inflammation due to A fumigatus. The presence of these antibodies have been correlated with decreased lung function.36'37 Nikolazik et all0 have described CF patients with A fumigatus specific IgE and IgG but no evidence of full blown ABPA. They have also shown that the major response is to a high molecular weight antigen of A fumigatus selectively released when A fumigatus is cocultured with P aeruginosa. 38 Increased levels of specific IgE to capsulated P aeruginosa were detected over noncapsulated P aeruginosa in both CF and CF/ABPA groups. The P aeruginosa specific IgE has been reported before in patients with chronic P aeruginosa infection.39 Contrary to other reports,40'41 we did not detect significant levels of P aeruginosa specific IgG in the serum of patients over controls. This may be from differences in the coating antigens used in ELISA in the present study. Cordon et al42 have shown that IgG antibodies titers in sputum may be undetectable in early P aeruginosa infection.
The P aeruginosa specific antibody levels produced in vitro were the reverse of what was detected in serum from these patients. This leads us to speculate the presence of circulating immune complexes formed by the specific IgG antibodies making them unavailable in serum. The extent to which immune complexes involving P aeruginosa antigens contribute to the pathogenesis of pulmonary damage in CF is still under consideration.43
The present study showed that the Con A nonbinding antigen specifically stimulated cells from patients with cystic fibrosis and ABPA while the P aeruginosa antigens were more immunogenic to patients with cystic fibrosis alone. Also, both patient groups produce significant amounts of antibodies to CHEST / 106/ 2/AUGUST, 1994 517 both A fumigatus and P aeruginosa. The role of these antibodies in the pathogenesis of the human disease remains to be studied. We have recently shown the protective role of A fumigatus specific antibodies in a murine model of ABPA. 44 In summary, the results from this study indicate that while these tests may allow one to rule-in the diagnosis of ABPA with CF, a negative test at this point is not sufficient to rule-out such a diagnosis.
